• Issue

    Haemophilia: Volume 7, Issue 2

    133-233
    March 2001
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Articles

Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

S. Björkman,  A. D. Shapiro,  E. Berntorp, 
  • Pages: 133-139
  • First Published: 07 July 2008

Recombinant factor IX (BeneFix®) by adjusted continuous infusion: a study of stability, sterility and clinical experience

P. Chowdary,  H. Dasani,  J. A. H. Jones,  C. M. Loran,  A. Eldridge,  S. Hughes,  P. W. Collins, 
  • Pages: 140-145
  • First Published: 07 July 2008

Viral safety of a pasteurized, monoclonal antibody-purified factor VIII concentrate in previously untreated haemophilia A patients

C. S. Philipp,  FOR THE MONOCLATE-P STUDY GROUP , 
  • Pages: 146-153
  • First Published: 07 July 2008

Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

S. Haya,  M. F. LÓpez,  J. A. Aznar,  J. Batlle,  THE SPANISH IMMUNE TOLERANCE GROUP , 
  • Pages: 154-159
  • First Published: 07 July 2008

Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review

A. C. Dykes,  I. D. Walker,  G. D. O. Lowe,  R. C. Tait, 
  • Pages: 160-163
  • First Published: 07 July 2008

Acquired haemophilia: experiences with a standardized approach

M. Grünewald,  H. Beneke,  C. GÜthner,  A. Germowitz,  A. Brommer,  M. Griesshammer, 
  • Pages: 164-169
  • First Published: 07 July 2008

Utility of the PFA-100® for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations

E. J. Favaloro, 
  • Pages: 170-179
  • First Published: 07 July 2008

Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100® and vWF:CBA as combined diagnostic strategies

E. J. Favaloro,  G. Kershaw,  M. Bukuya,  M. Hertzberg,  J. Koutts, 
  • Pages: 180-189
  • First Published: 07 July 2008

Validity of health status measurement with the Dutch Arthritis Impact Measurement Scale 2 in individuals with severe haemophilia

E. W. P. De Joode,  N. L. U. Van Meeteren,  H. M. Van Den Berg,  P. De Kleijn,  P. J. M. Helders, 
  • Pages: 190-197
  • First Published: 07 July 2008

Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia

J. M. Soucie,  J. Symons IV,  B. Evatt,  D. Brettler,  H. Huszti,  J. Linden,  THE HEMOPHILIA SURVEILLANCE SYSTEM PROJECT INVESTIGATORS , 
  • Pages: 198-206
  • First Published: 07 July 2008

Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis

G. Hortelano,  L. Wang,  N. Xu,  F. A. Ofosu, 
  • Pages: 207-214
  • First Published: 07 July 2008

Case Reports

High-titre factor VIII inhibitor in two children with mild haemophilia A

J. J. Puetz,  J. D. Bouhasin, 
  • Pages: 215-219
  • First Published: 07 July 2008

Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate

P. A. Kouides,  L. Kulzer, 
  • Pages: 220-223
  • First Published: 07 July 2008

The pelvi-femoral incomplete bone bridge in a patient with mild haemophilia

S. Aydogdu,  A. Memis,  K. Kavakli,  C. Balkan, 
  • Pages: 224-226
  • First Published: 07 July 2008

Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa†

S. Sheth,  D. Dimichele,  M. Lee,  J. Lamour,  J. Quaegebeur,  D. Hsu,  L. Addonizio,  S. Piomelli, 
  • Pages: 227-232
  • First Published: 07 July 2008

Announcement

Angelo Bianchi Bonomi Prize for congenital coagulation disorders

  • Page: 233
  • First Published: 07 July 2008